Cited by 305Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Open access

Morgan, Celia J. A., Schafer, Gráinne, Freeman, Tom P., Curran, H. Valerie·2010·British Journal of Psychiatry

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid. AIMS: To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings. METHOD: Cannabis users (n = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared. RESULTS: Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated. CONCLUSIONS: The antagonistic effects of cannabidiol at the CB(1) receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like 'skunk' and encouraged to use strains containing higher levels of cannabidiol.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.110.077503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Rivermead Behavioural Memory Test
la Cour, P., & GALLAGHER, K. (1990) · Nordisk Psykologi · doi:10.1080/00291463.1990.10636996 · Cited by 992
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Wechsler Test of Adult Reading
(2001) · PsycTESTS Dataset · doi:10.1037/t15180-000 · Cited by 616

Flagged first, then by citations

Show all 30 references

Research works printed but not linked: 5

10.1038/sj.npp.1300496 · DOI · Paper page
2006, Annual Report 2006: The State of the Drugs Problem in Europe
2009, Health Survey Findings for England 2008
Hardwick, 2008, Home Office Cannabis Potency Study
10.1016/j.biopsych.2006.08.027 · DOI

Sorted by citations

Items 101–200 of 305

The Behavioral Sequelae of Cannabis Use in Healthy People: A Systematic Review
Sorkhou, M., Bedder, R. H., & George, T. P. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.630247 · Cited by 61
A scoping review of the use of cannabidiol in psychiatric disorders
Kirkland, A. E., Fadus, M. C., Gruber, S. A., Gray, K. M., Wilens, T. E., & Squeglia, L. M. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114347 · Cited by 63
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone, J. M. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311400779 · Cited by 60
Investigating the interaction between schizotypy, divergent thinking and cannabis use
Schäfer, G., Feilding, A., Morgan, C. J. A., Agathangelou, M., Freeman, T. P., & Curran, H. V. (2012) · Consciousness and Cognition · doi:10.1016/j.concog.2011.11.009 · Cited by 59
Perioperative Pain and Addiction Interdisciplinary Network (PAIN): consensus recommendations for perioperative management of cannabis and cannabinoid-based medicine users by a modified Delphi process
Ladha, K. S., McLaren-Blades, A., Goel, A., Buys, M. J., Farquhar-Smith, P. W., Haroutounian, S., Kotteeswaran, Y., Kwofie, K., Foll, B. L., Lightfoot, N. J., et al. (2020) · British Journal of Anaesthesia · doi:10.1016/j.bja.2020.09.026 · Cited by 62
A Multiple‐Dose, Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group QT/QTc Study to Evaluate the Electrophysiologic Effects of THC/CBD Spray
Sellers, E. M., Schoedel, K. A., Bartlett, C., Romach, M. K., Russo, E. B., Stott, C. G., Wright, S., White, L., Duncombe, P., & Chen, C. (2013) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.36 · Cited by 57
Repeated Δ9-Tetrahydrocannabinol Exposure in Adolescent Monkeys: Persistent Effects Selective for Spatial Working Memory
Verrico, C. D., Gu, H., Peterson, M. L., Sampson, A. R., & Lewis, D. A. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13030335 · Cited by 56
Prevalence and correlates of medical cannabis patients' use of cannabis for recreational purposes
Morean, M. E., & Lederman, I. R. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.02.003 · Cited by 56
Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis
van Winkel, R., & Kuepper, R. (2014) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032813-153631 · Cited by 56
Medical use of cannabis. Cannabidiol: A new light for schizophrenia?
Deiana, S. (2012) · Drug Testing and Analysis · doi:10.1002/dta.1425 · Cited by 54
Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Senn, L., Cannazza, G., & Biagini, G. (2020) · Pharmaceuticals · doi:10.3390/ph13080174 · Cited by 55
Cannabidiol: Bridge between Antioxidant Effect, Cellular Protection, and Cognitive and Physical Performance
Jîtcă, G., Ősz, B. E., Vari, C.-E., Rusz, C.-M., Tero-Vescan, A., & Puşcaş, A. (2023) · Antioxidants · doi:10.3390/antiox12020485 · Cited by 58
Unraveling the Intoxicating and Therapeutic Effects of Cannabis Ingredients on Psychosis and Cognition
Colizzi, M., Ruggeri, M., & Bhattacharyya, S. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.00833 · Cited by 51
Cannabis—A Valuable Drug That Deserves Better Treatment
Mechoulam, R. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.12.002 · Cited by 49
A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆9-tetrahydrocannabinol (THC) by vaporisation
Solowij, N., Broyd, S. J., van Hell, H. H., & Hazekamp, A. (2014) · BMC Pharmacology and Toxicology · doi:10.1186/2050-6511-15-58 · Cited by 48
Cannabidiol in the context of substance use disorder treatment: A systematic review
Paulus, V., Billieux, J., Benyamina, A., & Karila, L. (2022) · Addictive Behaviors · doi:10.1016/j.addbeh.2022.107360 · Cited by 52
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
Kanaan, A. S., Jakubovski, E., & Müller‐Vahl, K. (2017) · Brain Sciences · doi:10.3390/brainsci7050047 · Cited by 47
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis
Hahn, B. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx105 · Cited by 52
Emerging potential of cannabidiol in reversing proteinopathies
Dash, R., Ali, M. C., Jahan, I., Munni, Y. A., Mitra, S., Hannan, M. A., Timalsina, B., Oktaviani, D. F., Choi, H. J., & Moon, I. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101209 · Cited by 50
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure
Pintori, N., Caria, F., Luca, M. A. D., & Miliano, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065251 · Cited by 50
Effects of Cannabidiol on Morphine Conditioned Place Preference in Mice
Markos, J., Harris, H. M., Gul, W., ElSohly, M. A., & Sufka, K. J. (2017) · Planta Medica · doi:10.1055/s-0043-117838 · Cited by 47
Acute effects of high-potency cannabis flower and cannabis concentrates on everyday life memory and decision making
Cuttler, C., LaFrance, E. M., & Stueber, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-93198-5 · Cited by 52
Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)
Nazario, L. R., Antonioli, R., Capiotti, K. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., Bonan, C. D., & da Silva, R. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.06.008 · Cited by 50
The Yin and Yang of Cannabis-induced Psychosis: the Actions of Δ 9-Tetrahydrocannabinol and Cannabidiol in Rodent Models of Schizophrenia
Arnold, J. C., Boucher, A. A., & Karl, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884726 · Cited by 45
Changes in the composition of cannabis from 2000–2017 in Denmark: Analysis of confiscated samples of cannabis resin.
Thomsen, K. R., Lindholst, C., Thylstrup, B., Kvamme, S. L., Reitzel, L. A., Worm‐Leonhard, M., Englund, A., Freeman, T. P., & Hesse, M. (2019) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000303 · Cited by 44
An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry
Olsson, F., Erridge, S., Tait, J., Holvey, C., Coomber, R., Beri, S., Hoare, J. M., Khan, S. A., Weatherall, M. W., Platt, M. W., et al. (2023) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2023.2183841 · Cited by 44
Use of Medical Cannabis to Treat Traumatic Brain Injury
Hergert, D. C., Robertson‐Benta, C. R., Sicard, V., Schwotzer, D., Hutchison, K. E., Covey, D. P., Quinn, D. K., Sadek, J. R., McDonald, J. D., & Mayer, A. R. (2020) · Journal of Neurotrauma · doi:10.1089/neu.2020.7148 · Cited by 45
CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders – Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study
Müller‐Vahl, K., Pisarenko, A., Szejko, N., Haas, M., Fremer, C., Jakubovski, E., Musil, R., Münchau, A. M., Neuner, I., Huys, D., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115135 · Cited by 41
Aging circadian rhythms and cannabinoids
Hodges, E. L., & Ashpole, N. M. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.008 · Cited by 44
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
Woelfl, T., Rohleder, C., Mueller, J. K., Lange, B., Reuter, A. R., Schmidt, A. M., Koethe, D., Hellmich, M., & Leweke, F. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.576877 · Cited by 41
The acute effects of cannabis on human executive function
Oomen, P. P., van Hell, H. H., & Bossong, M. G. (2018) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000426 · Cited by 45
The effects of acute cannabidiol on cerebral blood flow and its relationship to memory: An arterial spin labelling magnetic resonance imaging study
Bloomfield, M., Green, S. F., Hindocha, C., Yamamori, Y., Yim, J. L., Jones, A., Walker, H. R., Tokarczuk, P. F., Statton, B. K., Howes, O. D., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936419 · Cited by 42
A Placebo-Controlled Trial of Cannabinoid Treatment for Disruptive Behavior in Children and Adolescents with Autism Spectrum Disorder: Effects on Sleep Parameters as Measured by the CSHQ
Schnapp, A., Harel, M., Cayam-Rand, D., Cassuto, H., Polyansky, L., & Aran, A. A. (2022) · Biomedicines · doi:10.3390/biomedicines10071685 · Cited by 42
Acute effects of cannabigerol on anxiety, stress, and mood: a double-blind, placebo-controlled, crossover, field trial
Cuttler, C., Stueber, A., Cooper, Z. D., & Russo, E. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-66879-0 · Cited by 38
Interactions between cannabidiol and Δ9-THC following acute and repeated dosing: Rebound hyperactivity, sensorimotor gating and epigenetic and neuroadaptive changes in the mesolimbic pathway
Todd, S. M., Zhou, C., Clarke, D. J., Chohan, T. W., Bahceci, D., & Arnold, J. C. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.12.004 · Cited by 40
Cannabidiol modulation of hippocampal glutamate in early psychosis
O’Neill, A., Annibale, L., Blest‐Hopley, G., Wilson, R. P., Giampietro, V., & Bhattacharyya, S. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211001107 · Cited by 37
An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results
Sagar, K. A., Dahlgren, M. K., Lambros, A. M., Smith, R. T., El-Abboud, C., & Gruber, S. A. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000114 · Cited by 40
The effects of cannabidiol on impulsivity and memory during abstinence in cigarette dependent smokers
Hindocha, C., Freeman, T. P., Grabski, M., Crudgington, H., Davies, A. C., Stroud, J., Das, R. K., Lawn, W., Morgan, C. J. A., & Curran, H. V. (2018) · Scientific Reports · doi:10.1038/s41598-018-25846-2 · Cited by 37
Cognitive Safety Data from a Randomized, Double‐Blind, Parallel‐Group, Placebo‐Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9 ‐Tetrahydrocannabinol Drug on Parkinson's Disease‐Related Motor Symptoms
Domen, C. H., Sillau, S., Liu, Y., Adkins, M., Rajkovic, S. N., Bainbridge, J. L., Sempio, C., Klawitter, J., & Leehey, M. A. (2023) · Movement Disorders · doi:10.1002/mds.29447 · Cited by 36
Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks
Silveira, M. M., Arnold, J. C., Laviolette, S. R., Hillard, C. J., Celorrio, M., Aymerich, M. S., & Adams, W. K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.007 · Cited by 38
Synthesis of (−)‐Cannabimovone and Structural Reassignment of Anhydrocannabimovone through Gold(I)‐Catalyzed Cycloisomerization
Carreras, J., Kirillova, M. S., & Echavarren, A. M. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601834 · Cited by 34
Interactions between recreational cannabis use and cognitive function: lessons from functional magnetic resonance imaging
Sagar, K. A., & Gruber, S. A. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13990 · Cited by 36
Cannabinoids for Neuropathic Pain
Fine, P. G., & Rosenfeld, M. J. (2014) · Current Pain and Headache Reports · doi:10.1007/s11916-014-0451-2 · Cited by 32
Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages
Kruger, D. J., Kruger, J. S., & Collins, R. L. (2020) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2020.1752150 · Cited by 31
Cannabinoids for pediatric epilepsy? Up in smoke or real science?
Filloux, F. M. (2015) · PubMed Central · doi:10.3978/j.issn.2224-4336.2015.10.03 · Cited by 30
Neuroprotection Following Concussion: The Potential Role for Cannabidiol
Singh, J., & Neary, J. P. (2020) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/cjn.2020.23 · Cited by 30
Crosstalk between the endocannabinoid and mid-brain dopaminergic systems: Implication in dopamine dysregulation
Kibret, B. G., Canseco-Alba, A., Onaivi, E. S., & Engidawork, E. (2023) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2023.1137957 · Cited by 30
Additive effects of 3,4-methylenedioxymethamphetamine (MDMA) and compassionate imagery on self-compassion in recreational users of ecstasy
Kamboj, S. K., Walldén, Y. S. E., Falconer, C. J., Alotaibi, M. R., Blagbrough, I. S., Husbands, S. M., & Freeman, T. P. (2018) · Mindfulness · doi:10.1007/s12671-017-0849-0 · Cited by 28
Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.
Jacobs, D. S., Kohut, S. J., Jiang, S., Nikas, S. P., Makriyannis, A., & Bergman, J. (2016) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000081 · Cited by 28
Learning and memory is modulated by cannabidiol when administered during trace fear-conditioning
Uhernik, A. L., Montoya, Z. T., Balkissoon, C. D., & Smith, J. P. (2018) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2018.02.009 · Cited by 28
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
Jakubovski, E., Pisarenko, A., Fremer, C., Haas, M., May, M., Schumacher, C., Schindler, C., Häckl, S., Dávila, L. A., Koch, A., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.575826 · Cited by 28
The effect of interactions between genetics and cannabis use on neurocognition. A review
Cosker, E., Schwitzer, T., Ramoz, N., Ligier, F., Lalanne, L., Gorwood, P. A. P. M., Schwan, R., & Laprévote, V. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.024 · Cited by 29
Cannabis and Autoimmunity: Possible Mechanisms of Action
Giorgi, V., Marotto, D., Batticciotto, A., Atzeni, F., Bongiovanni, S. F., & Sarzi‐Puttini, P. (2021) · ImmunoTargets and Therapy · doi:10.2147/itt.s267905 · Cited by 31
Towards a better cannabis drug
Mechoulam, R., & Parker, L. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12400 · Cited by 26
Cannabidiol enhances verbal episodic memory in healthy young participants: A randomized clinical trial
Hotz, J., Fehlmann, B., Papassotiropoulos, A., de Quervain, D. J. ‐., & Schicktanz, N. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.09.007 · Cited by 26
Endocannabinoids as Therapeutic Targets
Prospero-Garcia, O. E., Ruiz‐Contreras, A. E., Ortega-Gómez, A., Herrera-Solís, A., & Méndez‐Díaz, M. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.09.005 · Cited by 26
Urinary cannabinoid levels during nabiximols (Sativex®)-medicated inpatient cannabis withdrawal.
Kevin, R. C., Allsop, D. J., Lintzeris, N., Dunlop, A. J., Booth, J., & McGregor, I. S. (2017) · Forensic Toxicology · doi:10.1007/s11419-016-0330-0 · Cited by 24
Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates
Withey, S. L., Kangas, B. D., Charles, S., Gumbert, A. B., Eisold, J. E., George, S. R., Bergman, J., & Madras, B. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108629 · Cited by 24
Cannabis-Induced Depersonalization Disorder in Adolescence
Hürlimann, F., Kupferschmid, S., & Simon, A. E. (2012) · Neuropsychobiology · doi:10.1159/000334605 · Cited by 25
Exploring cannabis use by patients with multiple sclerosis in a state where cannabis is legal
Weinkle, L. J., Domen, C. H., Shelton, I. T., Sillau, S., Nair, K. V., & Álvarez, E. (2018) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.022 · Cited by 25
Association of Marijuana Use with Changes in Cognitive Processing Speed and Flexibility for 17 Years in HIV-Seropositive and HIV-Seronegative Men
Okafor, C. N., Plankey, M. W., Li, M. J., Chen, X., Surkan, P. J., SHOPTAW, S. J., Martin, E. M., Cohen, R. A., Sacktor, N. C., & Cook, R. L. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2018.1495736 · Cited by 24
Acute effects of cannabis on speech illusions and psychotic-like symptoms: two studies testing the moderating effects of cannabidiol and adolescence
Mokrysz, C., Shaban, N. D. C., Freeman, T. P., Lawn, W., Pope, R. A., Hindocha, C., Freeman, A. M., Wall, M. B., Bloomfield, M., Morgan, C. J. A., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720001038 · Cited by 24
Delayed preattentional functioning in early psychosis patients with cannabis use
Pesa, N., Hermens, D. F., Battisti, R. A., Kaur, M., Hickie, I. B., & Solowij, N. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2676-2 · Cited by 23
Molecular Mechanisms of Cannabis Signaling in the Brain
Ronan, P. J., Wongngamnit, N., & Beresford, T. P. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.002 · Cited by 25
Cannabis Use and Psychosis: Theme Introduction
Martinotti, G., Iorio, G. D., Sepede, G., Berardis, D. D., Risio, L. D., & Giannantonio, M. D. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884627 · Cited by 22
Δ 9 tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques
Taffe, M. A. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112443743 · Cited by 22
Cannabidiol and Delta-9-Tetrahydrocannabinol Interactions in Male and Female Rats With Persistent Inflammatory Pain
Britch, S. C., & Craft, R. M. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.09.002 · Cited by 23
Considering abuse liability and neurocognitive effects of cannabis and cannabis-derived products when assessing analgesic efficacy: a comprehensive review of randomized-controlled studies
Cooper, Z. D., & Abrams, D. I. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669628 · Cited by 21
The effect of cannabis toxicity on a model microbiome bacterium epitomized by a panel of bioluminescent E. coli
Harpaz, D., Veltman, B., Sadeh, Y., Marks, R. S., Bernstein, N., & Eltzov, E. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.128241 · Cited by 20
Chronic Pain and Cannabidiol in Animal Models: Behavioral Pharmacology and Future Perspectives
Silva-Cardoso, G. K., & Leite‐Panissi, C. R. A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0096 · Cited by 22
Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder
Lees, R., Hines, L. A., Hindocha, C., Baio, G., Shaban, N. D. C., Stothart, G., Mofeez, A., Morgan, C. J. A., Curran, H. V., & Freeman, T. P. (2023) · Psychopharmacology · doi:10.1007/s00213-022-06303-5 · Cited by 19
Interaction of Cannabis Use and Aging: From Molecule to Mind
Yoo, H. B., DiMuzio, J. M., & Filbey, F. M. (2019) · Journal of Dual Diagnosis · doi:10.1080/15504263.2019.1665218 · Cited by 21
The Complex Relationship Between Cannabis Use and Mental Health: Considering the Influence of Cannabis Use Patterns and Individual Factors
Sagar, K. A., & Gruber, S. A. (2025) · CNS Drugs · doi:10.1007/s40263-024-01148-2 · Cited by 19
Cannabis, psychosis and the thalamus: A theoretical review
Vukadinovic, Z., Herman, M., & Rosenzweig, I. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.013 · Cited by 18
Cannabis potency: the need for global monitoring
Freeman, T. P., & Swift, W. (2015) · Addiction · doi:10.1111/add.13207 · Cited by 18
Neurocognitive effects of cannabis: Lessons learned from human experimental studies
Colizzi, M., & Bhattacharyya, S. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.010 · Cited by 19
Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users
Cohen, K., Rosenzweig, S., Rosca, P., Pinhasov, A., Weizman, A., & Weinstein, A. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00355 · Cited by 18
Harm to Others from Substance Use and Abuse: The Underused Potential in Nationwide Registers
Lund, I. O., & Bukten, A. (2015) · Substance Abuse Research and Treatment · doi:10.4137/sart.s23545 · Cited by 18
Reprint of “Caffeine protects against memory loss induced by high and non-anxiolytic dose of cannabidiol in adult zebrafish (Danio rerio)”
Nazario, L. R., Antonioli, R., Capiotti, K. M., Hallak, J. E. C., Zuardi, A. W., Crippa, J. A. S., Bonan, C. D., & da Silva, R. S. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.11.002 · Cited by 18
Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)
Lo, L. A., Christiansen, A. L., Strickland, J. C., Pistawka, C. A., Eadie, L., Vandrey, R. G., & MacCallum, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01847-w · Cited by 22
Examination of the effects of cannabinoid ligands on decision making in a rat gambling task
Ferland, J. N., Carr, M. R., Lee, A. M., Hoogeland, M. E., Winstanley, C. A., & Pattij, T. (2018) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2018.05.012 · Cited by 17
Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
Hindocha, C., Quattrone, D., Freeman, T. P., Murray, R. M., Mondelli, V., Breen, G. D., Curtis, C. J. C., Morgan, C. J. A., Curran, H. V., & Forti, M. D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0823-9 · Cited by 17
Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts
Sainz-Cort, A., Jiménez-Garrido, D. F., Marrón, E. M., Viejo-Sobera, R., Heeroma, J. H., & Bouso, J. C. (2021) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001457 · Cited by 17
Popular intoxicants: what lessons can be learned from the last 40 years of alcohol and cannabis regulation?
Weissenborn, R., & Nutt, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111414751 · Cited by 17
Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
Casey, S. L., & Vaughan, C. W. (2018) · Medicines · doi:10.3390/medicines5030067 · Cited by 19
Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
Curran, T., Devillez, H., YorkWilliams, S. L., & Bidwell, L. C. (2020) · Journal of Cannabis Research · doi:10.1186/s42238-020-00034-0 · Cited by 16
Modulation of cognitive and emotional processing by cannabidiol: the role of the anterior cingulate cortex
Kowal, M. A., Hazekamp, A., Colzato, L. S., van Steenbergen, H., & Hommel, B. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00147 · Cited by 16
Why medical cannabis is still out of patients’ reach—an essay by David Nutt
Nutt, D. (2019) · BMJ · doi:10.1136/bmj.l1903 · Cited by 16
Les troubles cognitifs et psychiatriques liés à la consommation de cannabis
Dervaux, A., Krebs, M., & Laqueille, X. (2014) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)31322-6 · Cited by 19
Does cannabidiol protect against the negative effects of THC?
Henquet, C., & Kuepper, R. (2010) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.110.081380 · Cited by 16
Impact of Adolescent Cannabis Use on Neurocognitive and Brain Development
Scott, J. C. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.06.002 · Cited by 16
Effects of oral Δ9-tetrahydrocannabinol and cannabidiol combinations on a sustained attention task in rats.
Moore, C. F., Davis, C. M., Sempio, C., Klawitter, J., Christians, U., & Weerts, E. M. (2023) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000635 · Cited by 15
Preliminary Evidence for Cannabis and Nicotine Urinary Metabolites as Predictors of Verbal Memory Performance and Learning Among Young Adults
Wade, N. E., Baca, R. E., Courtney, K. E., McCabe, C. J., Infante, M. A., Huestis, M. A., & Jacobus, J. (2021) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617721000205 · Cited by 15
Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
Sokolaj, E. E., Assareh, N., Anderson, K. E., Aubrey, K. R., & Vaughan, C. W. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15964 · Cited by 16
A “Good” Smoke? The Off-Label Use of Cannabidiol to Reduce Cannabis Use
Fortin, D., Beo, V. D., Massin, S., Bisiou, Y., Carrieri, P., & Barré, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.829944 · Cited by 14
Whole Organisms or Pure Compounds? Entourage Effect Versus Drug Specificity
Ribeiro, S. T. G. (2018) · Springer eBooks · doi:10.1007/978-3-319-76720-8_8 · Cited by 14
Cannabinoids, Inner Ear, Hearing, and Tinnitus: A Neuroimmunological Perspective
Perin, P., Tagne, A. M., Enrico, P., Marino, F., Cosentino, M., Pizzala, R., & Boselli, C. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.505995 · Cited by 15
A Multiple Correspondence Analysis of Patterns of CBD Use in Hemp and Marijuana Users
Vilches, J. R., Taylor, M. B., & Filbey, F. M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.624012 · Cited by 14
Should oncologists trust cannabinoids?
Creangă-Murariu, I., Filipiuc, L.-E., Cuciureanu, M. D., Tamba, B.-I., & Alexa‐Stratulat, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1211506 · Cited by 13
Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research
Schoeler, T., Baldwin, J. R., Martin, E., Barkhuizen, W., & Pingault, J. (2024) · Nature Mental Health · doi:10.1038/s44220-024-00261-x · Cited by 13

Authors: Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V.
Affiliations: University College London (GB)
Corresponding author: Curran, H. Valerie
ORCID: Morgan, Celia J. A.
Freeman, Tom P.
Curran, H. Valerie
Venue: British Journal of Psychiatry
Publisher: Royal College of Psychiatrists
Published: 2010-10
Volume: 197
Issue: 4
Pages: 285-290
ISSN: 0007-1250 (ISSN-L)
1472-1465
DOI: 10.1192/bjp.bp.110.077503
OpenAlex: W2015441565
Cited by: 305
References: 30
Citations by year: 2026: 4 · 2025: 11 · 2024: 8 · 2023: 23 · 2022: 13 · 2021: 20 · 2020: 31 · 2019: 24 · 2018: 26 · 2017: 25 · 2016: 22 · 2015: 20 · 2014: 20 · 2013: 17 · 2012: 23
FWCI: 13.45
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified, 2650 d)
Locations: The British Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: cannabidiol, delta-9-tetrahydrocannabinol, cannabis smoking, psychotomimetic effects, CB1 receptor antagonism, harm reduction, prose recall, cannabis users
MeSH terms: Adolescent, Alcohol Drinking, Analysis of Variance, Cannabidiol, Cannabinoids, Female, United Kingdom, Humans, Male, Marijuana Smoking, Memory, Memory Disorders, Psychiatric Status Rating Scales, Mental Recall, Saliva, Dronabinol, Verbal Learning, Receptor, Cannabinoid, CB1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks